journal article·2019-12

An injectable peptide hydrogel for reconstruction of the human trabecular meshwork

Kosala D. Waduthanthri, Yuan He, Carlo Montemagno, Sibel Cetinel

Acta Biomaterialia· Volume 100
Publisher page

Abstract

Glaucoma is a leading cause of irreversible blindness worldwide. Current treatments of glaucoma involve lowering the IOP by means of decreasing aqueous humor production or increasing non-trabecular aqueous humor outflow with the help of IOP-lowering eye drops, nanotechnology enabled glaucoma drainage implants, and trabeculectomy. However, there is currently no effective and permanent cure for this disease. In order to investigate new therapeutic strategies, three dimensional (3D) biomimetic trabecular meshwork (TM) models are in demand. Therefore, we adapted MAX8B, a peptide hydrogel system to bioengineer a 3D trabecular meshwork scaffold. We assessed mechanical and bio-instructive properties of this engineered tissue matrix by using rheological analysis, 3D cell culture and imaging techniques. The scaffold material exhibited shear-thinning ability and biocompatibility for proper hTM growth and proliferation indicating a potential utilization as an injectable implant. Additionally, by using a perfusion system, MAX8B scaffold was tested as an in vitro platform for investigating the effect of Dexamethasone (Dex) on trabecular meshwork outflow facility. The physiological response of hTM cells within the scaffold to Dex treatment clearly supported the effectiveness of this 3D model as a drug-testing platform, which can accelerate discovery of new therapeutic targets for glaucoma. STATEMENT OF SIGNIFICANCE: Artificial 3D-TM (3-dimentional Trabecular Meshwork) developed here with hTM (human TM) cells seeded on peptide-hydrogel scaffolds exhibits the mechanical strength and physiological properties mimicking the native TM tissue. Besides serving a novel and effective 3D-TM model, the MAX8B hydrogel could potentially function as an injectable trabecular meshwork implant.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Glaucoma and retinal disorders · Proteoglycans and glycosaminoglycans research · Ocular Surface and Contact Lens

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (49)

Show source-provided references
1. The trabecular meshwork outflow pathways: structural and functional aspects10.1016/j.exer.2009.02.007 ↗
2. Walking through trabecular meshwork biology: toward engineering design of outflow physiology10.1016/j.biotechadv.2014.04.012 ↗
3. Extracellular matrix turnover and outflow resistance10.1016/j.exer.2008.11.023 ↗
4. The pathophysiology and treatment of glaucoma: a review10.1001/jama.2014.3192 ↗
5. The number of people with glaucoma worldwide in 2010 and 202010.1136/bjo.2005.081224 ↗
6. Measurement of aqueous humor flow10.1016/j.exer.2008.10.018 ↗
7. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial10.1001/archopht.120.10.1268 ↗
8. Novel therapeutics in glaucoma management10.2174/1570159X15666170915142727 ↗
9. Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with β adrenergic antagonists10.1136/bjo.84.2.181 ↗
10. Glaucoma drainage implants: a critical comparison of types10.1097/01.icu.0000193080.55240.7e ↗
11. Management of hypotony after glaucoma filtering surgery10.1016/j.tjo.2014.05.003 ↗
12. Risk factors and long-term outcomes in patients with low intraocular pressure after trabeculectomy10.1016/j.ophtha.2017.05.014 ↗
13. Analyzing live cellularity in the human trabecular meshwork10.1167/iovs.12-10479 ↗
14. In vivo measurement of trabecular meshwork stiffness in a corticosteroid-induced ocular hypertensive mouse model10.1073/pnas.1814889116 ↗
15. Human ocular perfusion organ culture: a versatile ex vivo model for glaucoma research10.1097/00061198-200012000-00009 ↗
16. Recreating a human trabecular meshwork outflow system on microfabricated porous structures10.1002/bit.24977 ↗
17. Bioengineered glaucomatous 3D human trabecular meshwork as an in vitro disease model10.1002/bit.25899 ↗
18. A biomimetic schlemm's canal inner wall: a model to study outflow physiology, glaucoma pathology and high-throughput drug screening10.1016/j.biomaterials.2015.06.034 ↗
19. Collagen and collagen-chondroitin sulfate scaffolds with uniaxially aligned pores for the biomimetic, three dimensional culture of trabecular meshwork cells10.1002/bit.26206 ↗
20. Effect of benzalkonium chloride on trabecular meshwork cells in a new in vitro 3D trabecular meshwork model for glaucoma10.1016/j.tiv.2017.02.006 ↗
21. Consensus recommendations for trabecular meshwork cell isolation, characterization and culture10.1016/j.exer.2018.03.001 ↗
22. Biomaterials for regenerative medicine approaches for the anterior segment of the eye10.1002/adhm.201701328 ↗
23. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering10.1038/nbt1055 ↗
24. Controlling hydrogelation kinetics by peptide design for three-dimensional encapsulation and injectable delivery of cells10.1073/pnas.0701980104 ↗
25. Shear-thinning hydrogels for biomedical applications10.1039/C1SM06513K ↗
26. 9-Fluorenylmethoxycarbonyl amino-protecting group10.1021/jo00795a005 ↗
27. Solid phase peptide synthesis. I. the synthesis of a tetrapeptide10.1021/ja00897a025 ↗
28. Synthesis and primary characterization of self-assembled peptide-based hydrogels10.1007/978-1-59745-480-3_5 ↗
29. Establishment of human trabecular meshwork cell cultures using nontransplantable corneoscleral rims10.3906/biy-1810-69 ↗
30. Rheological properties of peptide-based hydrogels for biomedical and other applications10.1039/b919449p ↗
31. Regulation of tigr/myoc gene expression in human trabecular meshwork cells10.1038/eye.2000.137 ↗
32. Modulation of myocilin/tigr expression in human trabecular meshwork
33. The many faces of the trabecular meshwork cell10.1016/j.exer.2016.07.009 ↗
34. Macromolecular diffusion and release from self-assembled β-hairpin peptide hydrogels10.1016/j.biomaterials.2008.11.019 ↗
35. Cytocompatibility of self-assembled β-hairpin peptide hydrogel surfaces10.1016/j.biomaterials.2005.01.029 ↗
36. The role of integrins in the trabecular meshwork10.1089/jop.2013.0176 ↗
37. Differential effects of trabecular meshwork stiffness on outflow facility in normal human and porcine eyeseffects of trabecular meshwork stiffness on outflow10.1167/iovs.12-9825 ↗
38. Elastic modulus determination of normal and glaucomatous human trabecular meshwork10.1167/iovs.10-6342 ↗
39. Collagen distribution in the lamina cribrosa and the trabecular meshwork of the human eye10.1136/bjo.71.12.886 ↗
40. Morphological variability of the trabecular meshwork in glaucoma patients: implications for non-perforating glaucoma surgery10.1136/bjo.84.12.1354 ↗
41. The effect of intraocular pressure on resistance to outflow10.1016/0039-6257(77)90088-1 ↗
42. Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes
43. The effect of cytochalasin d on outflow facility and the trabecular meshwork of the human eye in perfusion organ culture
44. The extracellular matrix and its modulation in the trabecular meshwork10.1016/S0039-6257(96)80066-X ↗
45. Glucocorticoid induction of the glaucoma gene myoc in human and monkey trabecular meshwork cells and tissues
46. Aqueous humor flow during sleep
47. Extracellular matrix in the trabecular meshwork10.1016/j.exer.2008.01.013 ↗
48. Age-related changes in trabecular meshwork cellularity
49. Consensus recommendations for trabecular meshwork cell isolation, characterization and culture10.1016/j.exer.2018.03.001 ↗